JunB is a repressor of MMP-9 transcription in depolarized rat brain neurons

Molecular and Cellular Neuroscience

Volumn 40, Issue 1, 2009, Pages 98-110

  Rylski, Marcin ^a   Amborska, Renata ^a   Zybura, Katarzyna ^a   Michaluk, Piotr ^a,b   Bielinska, Beata ^a   Konopacki, Filip A ^a,c   Wilczynski, Grzegorz M ^a   Kaczmarek, Leszek ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c POSTGRADUATE SCHOOL OF MOLECULAR MEDICINE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MESSENGER RNA; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR JUNB;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ACTIVATION; CONTROLLED STUDY; DEPOLARIZATION; GENE EXPRESSION; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; CELLS, CULTURED; CONVULSANTS; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MALE; MATRIX METALLOPROTEINASE 9; MEMBRANE POTENTIALS; NEURONS; PENTYLENETETRAZOLE; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RATS; RATS, WISTAR; TRANSCRIPTION, GENETIC;

RATTUS;

EID: 57149147849     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2008.09.005     Document Type: Article

References (92)

1. Abraham D., Ponticos M., and Nagase H. Connective tissue remodeling: cross-talk between endothelins and matrix metalloproteinases. Curr. Vasc. Pharmacol. 3 (2005) 369-379
2. Alfonso-Jaume M.A., Bergman M.R., Mahimkar R., Cheng S., Jin Z.Q., Karliner J.S., and Lovett D.H. Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) H1838-1846
3. Antoniv T.T., Tanaka S., Sudan B., De Val S., Liu K., Wang L., Wells D.J., Bou-Gharios G., and Ramirez F. Identification of a repressor in the first intron of the human alpha2(I) collagen gene (COL1A2). J. Biol. Chem. 280 (2005) 35417-35423
4. Barath P., Poliakova D., Luciakova K., and Nelson B.D. Identification of NF1 as a silencer protein of the human adenine nucleotide translocase-2 gene. Eur. J. Biochem. 271 (2004) 1781-1788
5. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
6. Chakraborti S., Mandal M., Das S., Mandal A., and Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 253 (2003) 269-285
7. Chalaux E., Lopez-Rovira T., Rosa J.L., Bartrons R., and Ventura F. JunB is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2. J. Biol. Chem. 273 (1998) 537-543
8. Condorelli D.F., Dell, Albani P., Amico C., Lukasiuk K., Kaczmarek L., and Giuffrida-Stella A.M. Glutamate receptor-driven activation of transcription factors in primary neuronal cultures. Neurochem. Res. 19 (1994) 489-499
9. Crowe D.L., and Brown T.N. Transcriptional inhibition of matrix metalloproteinase 9 (MMP-9) activity by a c-fos/estrogen receptor fusion protein is mediated by the proximal AP-1 site of the MMP-9 promoter and correlates with reduced tumor cell invasion. Neoplasia 1 (1999) 368-372
10. Crowe D.L., Tsang K.J., and Shemirani B. Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. Neoplasia 3 (2001) 27-32
11. Das A., Fernandez-Zapico M.E., Cao S., Yao J., Fiorucci S., Hebbel R.P., Urrutia R., and Shah V.H. Disruption of an SP2/KLF6 repression complex by SHP is required for farnesoid X receptor-induced endothelial cell migration. J. Biol. Chem. 281 (2006) 39105-39113
12. Deschamps A.M., and Spinale F.G. Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation. Cardiovasc. Res. 69 (2006) 666-676
13. Dzwonek J., Rylski M., and Kaczmarek L. Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain. FEBS Lett. 567 (2004) 129-135
14. Eberhardt W., Schulze M., Engels C., Klasmeier E., and Pfeilschifter J. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors. Mol. Endocrinol. 16 (2002) 1752-1766
15. Eferl R., and Wagner E.F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3 (2003) 859-868
16. Elliott R.C., and Gall C.M. Changes in activating protein 1 (AP-1) composition correspond with the biphasic profile of nerve growth factor mRNA expression in rat hippocampus after hilus lesion-induced seizures. J. Neurosci. 20 (2000) 2142-2149
17. Erdtmann-Vourliotis M., Riechert U., Mayer P., Grecksch G., and Hollt V. Pentylenetetrazole (PTZ)-induced c-fos expression in the hippocampus of kindled rats is suppressed by concomitant treatment with naloxone. Brain Res. 792 (1998) 299-308
18. Farina A.R., Tacconelli A., Vacca A., Maroder M., Gulino A., and Mackay A.R. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. Cell Growth Differ. 10 (1999) 353-367
19. Filipkowski R.K., Hetman M., Kaminska B., and Kaczmarek L. DNA fragmentation in rat brain after intraperitoneal administration of kainate. Neuroreport 5 (1994) 1538-1540
20. Flood W.D., Moyer R.W., Tsykin A., Sutherland G.R., and Koblar S.A. Nxf and Fbxo33: novel seizure-responsive genes in mice. Eur. J. Neurosci. 20 (2004) 1819-1826
21. Gilbert M.E. Does the kindling model of epilepsy contribute to our understanding of multiple chemical sensitivity?. Ann. N. Y. Acad. Sci. 933 (2001) 68-91
22. Gum R., Lengyel E., Juarez J., Chen J.H., Sato H., Seiki M., and Boyd D. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271 (1996) 10672-10680
23. Gum R., Wang H., Lengyel E., Juarez J., and Boyd D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14 (1997) 1481-1493
24. Guo Z., Du X., and Iacovitti L. Regulation of tyrosine hydroxylase gene expression during transdifferentiation of striatal neurons: changes in transcription factors binding the AP-1 site. J. Neurosci. 18 (1998) 8163-8174
25. Herdegen T., and Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28 (1998) 370-490
26. Hetman M., Kanning K., Cavanaugh J.E., and Xia Z. Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274 (1999) 22569-22580
27. Himelstein B.P., Lee E.J., Sato H., Seiki M., and Muschel R.J. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin. Exp. Metastasis 16 (1998) 169-177
28. Ho L.L., Chen W.J., Lin-Shiau S.Y., and Lin J.K. Penta-O-galloyl-beta-d-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1. Eur. J. Pharmacol. 453 (2002) 149-158
29. Hock T.D., Liby K., Wright M.M., McConnell S., Schorpp-Kistner M., Ryan T.M., and Agarwal A. JunB and JunD regulate human heme oxygenase-1 gene expression in renal epithelial cells. J. Biol. Chem. 282 (2007) 6875-6886
30. Hou Y.N., Cebers G., Terenius L., and Liljequist S. Characterization of NMDA- and AMPA-induced enhancement of AP-1 DNA binding activity in rat cerebellar granule cells. Brain Res. 754 (1997) 79-87
31. Hulboy D.L., Matrisian L.M., and Crawford H.C. Loss of JunB activity enhances stromelysin 1 expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors. Mol. Cell. Biol. 21 (2001) 5478-5487
32. Jaworski J., Biedermann I.W., Lapinska J., Szklarczyk A., Figiel I., Konopka D., Nowicka D., Filipkowski R.K., Hetman M., Kowalczyk A., and Kaczmarek L. Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus. J. Biol. Chem. 274 (1999) 28106-28112
33. Jaworski J., Mioduszewska B., Sanchez-Capelo A., Figiel I., Habas A., Gozdz A., Proszynski T., Hetman M., Mallet J., and Kaczmarek L. Inducible cAMP early repressor, an endogenous antagonist of cAMP responsive element-binding protein, evokes neuronal apoptosis in vitro. J. Neurosci. 23 (2003) 4519-4526
34. Kaczmarek L. Molecular biology of vertebrate learning: is c-fos a new beginning?. J. Neurosci. Res. 34 (1993) 377-381
35. Kaczmarek L., Lapinska-Dzwonek J., and Szymczak S. Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?. EMBO J. 21 (2002) 6643-6648
36. Kaminska B., Lukasiuk K., and Kaczmarek L. Seizures-evoked activation of transcription factors. Acta Neurobiol. Exp. (Wars) 54 (1994) 65-72
37. Kaminska B., Filipkowski R.K., Zurkowska G., Lason W., Przewlocki R., and Kaczmarek L. Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death. Eur. J. Neurosci. 6 (1994) 1558-1566
38. Kaminska B., Kaczmarek L., and Chaudhuri A. Visual stimulation regulates the expression of transcription factors and modulates the composition of AP-1 in visual cortex. J. Neurosci. 16 (1996) 3968-3978
39. Kobayashi T., Kishimoto J., Hattori S., Wachi H., Shinkai H., and Burgeson R.E. Matrix metalloproteinase 9 expression is coordinately modulated by the KRE-M9 and 12-O-tetradecanoyl-phorbol-13-acetate responsive elements. J. Invest. Dermatol. 122 (2004) 278-285
40. Kobierski L.A., Chu H.M., Tan Y., and Comb M.J. cAMP-dependent regulation of proenkephalin by JunD and JunB: positive and negative effects of AP-1 proteins. Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 10222-10226
41. Konishi Y., Matsu-ura T., Mikoshiba K., and Tamura T. Stimulation of gene expression of NeuroD-related factor in the mouse brain following pentylenetetrazol-induced seizures. Brain Res. Mol. Brain Res. 97 (2001) 129-136
42. Konopacki F.A., Rylski M., Wilczek E., Amborska R., Detka D., Kaczmarek L., and Wilczynski G.M. Synaptic localization of seizure-induced matrix metalloproteinase-9 mRNA. Neuroscience 150 (2007) 31-39
43. Lee J.G., Dahi S., Mahimkar R., Tulloch N.L., Alfonso-Jaume M.A., Lovett D.H., and Sarkar R. Intronic regulation of matrix metalloproteinase-2 revealed by in vivo transcriptional analysis in ischemia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 16345-16350
44. LeHoux J.G., and Lefebvre A. Novel protein kinase C-epsilon inhibits human CYP11B2 gene expression through ERK1/2 signalling pathway and JunB. J. Mol. Endocrinol. 36 (2006) 51-64
45. Li Y.T., Shen F., Liu B.H., and Cheng G.F. Resveratrol inhibits matrix metalloproteinase-9 transcription in U937 cells. Acta Pharmacol. Sin. 24 (2003) 1167-1171
46. Lidwell K., and Griffiths R. Possible role for the FosB/JunD AP-1 transcription factor complex in glutamate-mediated excitotoxicity in cultured cerebellar granule cells. J. Neurosci. Res. 62 (2000) 427-439
47. Liu N., Cigola E., Tinti C., Jin B.K., Conti B., Volpe B.T., and Baker H. Unique regulation of immediate early gene and tyrosine hydroxylase expression in the odor-deprived mouse olfactory bulb. J. Biol. Chem. 274 (1999) 3042-3047
48. Ma Z., Shah R.C., Chang M.J., and Benveniste E.N. Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 24 (2004) 5496-5509
49. Magid R., Murphy T.J., and Galis Z.S. Expression of matrix metalloproteinase-9 in endothelial cells is differentially regulated by shear stress. Role of c-Myc. J. Biol. Chem. 278 (2003) 32994-32999
50. Michaluk P., Kaczmarek L., 2007. Matrix metalloproteinase-9 in glutamate-dependent adult brain function and dysfunction. Cell Death Differ. 14, 1255-1258.
51. Moon S.K., Kim H.M., and Kim C.H. PTEN induces G1 cell cycle arrest and inhibits MMP-9 expression via the regulation of NF-kappaB and AP-1 in vascular smooth muscle cells. Arch. Biochem. Biophys. 421 (2004) 267-276
52. Moon S.K., Kang S.K., and Kim C.H. Reactive oxygen species mediates disialoganglioside GD3-induced inhibition of ERK1/2 and matrix metalloproteinase-9 expression in vascular smooth muscle cells. FASEB. J. 20 (2006) 1387-1395
53. Morgan J.I., and Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14 (1991) 421-451
54. Moshier J.A., Skunca M., Wu W., Boppana S.M., Rauscher III F.J., and Dosescu J. Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1. Nucleic Acids Res. 24 (1996) 1149-1157
55. Moulder K.L., Meeks J.P., and Mennerick S. Homeostatic regulation of glutamate release in response to depolarization. Mol. Neurobiol. 33 (2006) 133-153
56. Murono S., Yoshizaki T., Sato H., Takeshita H., Furukawa M., and Pagano J.S. Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res. 60 (2000) 2555-2561
57. Nair R.R., Solway J., and Boyd D.D. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. J. Biol. Chem. 281 (2006) 26424-26436
58. Nausch N., Florin L., Hartenstein B., Angel P., Schorpp-Kistner M., and Cerwenka A. Cutting edge: the AP-1 subunit JunB determines NK cell-mediated target cell killing by regulation of the NKG2D-ligand RAE-1epsilon. J. Immunol. 176 (2006) 7-11
59. Ni H., Jiang Y.W., Bo T., Wang J.M., and Wu X.R. c-Fos, N-methyl-d-aspartate receptor 2C, GABA-A-alpha1 immunoreactivity, seizure latency and neuronal injury following single or recurrent neonatal seizures in hippocampus of Wistar rat. Neurosci. Lett. 380 (2005) 149-154
60. Pratap J., Javed A., Languino L.R., van Wijnen A.J., Stein J.L., Stein G.S., and Lian J.B. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol. Cell. Biol. 25 (2005) 8581-8591
61. Quandt K., Frech K., Karas H., Wingender E., and Werner T. MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23 (1995) 4878-4884
62. Rajapakse N., Kim M.M., Mendis E., Huang R., and Kim S.K. Carboxylated chitooligosaccharides (CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1. Biochim. Biophys. Acta 1760 (2006) 1780-1788
63. Ray A., Bal B.S., and Ray B.K. Transcriptional induction of matrix metalloproteinase-9 in the chondrocyte and synoviocyte cells is regulated via a novel mechanism: evidence for functional cooperation between serum amyloid A-activating factor-1 and AP-1. J. Immunol. 175 (2005) 4039-4048
64. Rylski M., and Kaczmarek L. Ap-1 targets in the brain. Front. Biosci. 9 (2004) 8-23
65. Rylski M., Welch J.J., Chen Y.Y., Letting D.L., Diehl J.A., Chodosh L.A., Blobel G.A., and Weiss M.J. GATA-1-mediated proliferation arrest during erythroid maturation. Mol. Cell. Biol. 23 (2003) 5031-5042
66. Ryseck R.P., and Bravo R. c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene 6 (1991) 533-542
67. Sanceau J., Boyd D.D., Seiki M., and Bauvois B. Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B. J. Biol. Chem. 277 (2002) 35766-35775
68. Sato H., and Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8 (1993) 395-405
69. Sato H., Kita M., and Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268 (1993) 23460-23468
70. Schorpp-Kistner M., Wang Z.Q., Angel P., and Wagner E.F. JunB is essential for mammalian placentation. EMBO J. 18 (1999) 934-948
71. Schutte J., Viallet J., Nau M., Segal S., Fedorko J., and Minna J. jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 59 (1989) 987-997
72. Sivak J.M., West-Mays J.A., Yee A., Williams T., and Fini M.E. Transcription factors Pax6 and AP-2alpha interact to coordinate corneal epithelial repair by controlling expression of matrix metalloproteinase gelatinase B. Mol. Cell. Biol. 24 (2004) 245-257
73. Smeyne R.J., Vendrell M., Hayward M., Baker S.J., Miao G.G., Schilling K., Robertson L.M., Curran T., and Morgan J.I. Continuous c-fos expression precedes programmed cell death in vivo. Nature 363 (1993) 166-169
74. Smith L.M., Wise S.C., Hendricks D.T., Sabichi A.L., Bos T., Reddy P., Brown P.H., and Birrer M.J. cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype. Oncogene 18 (1999) 6063-6070
75. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
76. Suzuki T., Okuno H., Yoshida T., Endo T., Nishina H., and Iba H. Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19 (1991) 5537-5542
77. Szabowski A., Maas-Szabowski N., Andrecht S., Kolbus A., Schorpp-Kistner M., Fusenig N.E., and Angel P. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin. Cell 103 (2000) 745-755
78. Szklarczyk A., Lapinska J., Rylski M., McKay R.D., and Kaczmarek L. Matrix metalloproteinase-9 undergoes expression and activation during dendritic remodeling in adult hippocampus. J. Neurosci. 22 (2002) 920-930
79. Tabuchi A., Oh E., Taoka A., Sakurai H., Tsuchiya T., and Tsuda M. Rapid attenuation of AP-1 transcriptional factors associated with nitric oxide (NO)-mediated neuronal cell death. J. Biol. Chem. 271 (1996) 31061-31067
80. Taheri F., and Bazan H.E. Platelet-activating factor overturns the transcriptional repressor disposition of sp1 in the expression of mmp-9 in human corneal epithelial cells. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1931-1941
81. Textor B., Sator-Schmitt M., Richter K.H., Angel P., and Schorpp-Kistner M. c-Jun and JunB are essential for hypoglycemia-mediated VEGF induction. Ann. N. Y. Acad. Sci. 1091 (2006) 310-318
82. Troussard A.A., Costello P., Yoganathan T.N., Kumagai S., Roskelley C.D., and Dedhar S. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19 (2000) 5444-5452
83. Van den Steen P.E., Dubois B., Nelissen I., Rudd P.M., Dwek R.A., and Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 37 (2002) 375-536
84. Watanabe M., Ogawa Y., Ito K., Higashihara M., Kadin M.E., Abraham L.J., Watanabe T., and Horie R. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells. Am. J. Pathol. 163 (2003) 633-641
85. Watanabe M., Sasaki M., Itoh K., Higashihara M., Umezawa K., Kadin M.E., Abraham L.J., Watanabe T., and Horie R. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and Reed-Sternberg cells of Hodgkin lymphoma. Cancer Res. 65 (2005) 7628-7634
86. Weber J.R., and Skene J.H. The activity of a highly promiscuous AP-1 element can be confined to neurons by a tissue-selective repressive element. J. Neurosci. 18 (1998) 5264-5274
87. Wilczynski G.M., Konopacki F.A., Wilczek E., Lasiecka Z., Gorlewicz A., Michaluk P., Wawrzyniak M., Malinowska M., Okulski P., Kolodziej L.R., Konopka W., Duniec K., Mioduszewska B., Nikolaev E., Walczak A., Owczarek D., Gorecki D.C., Zuschratter W., Ottersen O.P., and Kaczmarek L. Important role of matrix metalloproteinase 9 in epileptogenesis. J. Cell Biol. 180 (2008) 1021-1035
88. Yan C., and Boyd D.D. Regulation of matrix metalloproteinase gene expression. J. Cell Physiol. 211 (2007) 19-26
89. Yan C., Wang H., Toh Y., and Boyd D.D. Repression of 92-kDa type IV collagenase expression by MTA1 is mediated through direct interactions with the promoter via a mechanism, which is both dependent on and independent of histone deacetylation. J. Biol. Chem. 278 (2003) 2309-2316
90. Yang J.Q., Zhao W., Duan H., Robbins M.E., Buettner G.R., Oberley L.W., and Domann F.E. v-Ha-RaS oncogene upregulates the 92-kDa type IV collagenase (MMP-9) gene by increasing cellular superoxide production and activating NF-kappaB. Free Radic. Biol. Med. 31 (2001) 520-529
91. Yong V.W. Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat. Rev. Neurosci. 6 (2005) 931-944
92. Zagulska-Szymczak S., Filipkowski R.K., and Kaczmarek L. Kainate-induced genes in the hippocampus: lessons from expression patterns. Neurochem. Int. 38 (2001) 485-501